Findings from a recent study showed potential associations between psoriasis, comorbid conditions, and sexual and erectile dysfunction among patients with this skin condition.

News

News
Monday, February 5, 2018
The National Psoriasis Foundation has opened the grant application process for undergraduate and medical students conducting research over the summer on psoriasis diseases.
News
Thursday, January 18, 2018
Researchers investigated the potential association between cutaneous lymphoma and anti-TNFα therapy in a recent study.
News
Monday, January 8, 2018
Recently, several new biologic agents have been released for the treatment of psoriatic arthritis. Researchers compared the safety and efficacy of these therapies in a recent meta-analysis.
News
Friday, December 22, 2017
Psoriasis is commonly treated by targeting Th17 cells and interleukin 17 cytokines. Although atopic dermatitis is often treated differently, certain subtypes of atopic dermatitis may benefit from certain aspects of psoriasis treatment.

NPF Endorsed Articles

NPF Endorsed Articles
Thursday, August 21, 2014
The interleukin-17A inhibitor secukinumab was effective in the treatment of psoriasis, according to 2 large studies. 
NPF Endorsed Articles
Tuesday, July 22, 2014
The link between psoriasis and other medical conditions such as psoriatic arthritis (PsA), cardiovascular disease, metabolic disorder, inflammatory bowel disease, psychiatric disorders, lymphoma and ocular disease is being recognized by a growing body of peer review literature. 

Research in Review

Research in Review
Tuesday, April 19, 2016
Posters presented at The Winter Clinical Dermatology Conference-Hawaii look at treatment options for psoriasis.
Research in Review
Monday, March 28, 2016
Gary Goldenberg, MD, discusses the latest oral agents for individuals living with psoriasis.
Research in Review
Thursday, February 11, 2016
In this excerpt from the recently published book, Practical Psoriasis Management, the authors discuss the use of secukinumab for moderate-to-severe psoriasis.   
Research in Review
Friday, December 18, 2015
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.